title: Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate.
abstract: Besides conferring some health benefit to the host, a bacterial strain must present an unambiguous safety status to be considered a probiotic. We here present the preliminary safety evaluation of a new Bacteroides xylanisolvens strain (DSM 23964) isolated from human feces. First results suggest that it may be able to provide probiotic health benefits. Its identity was confirmed by biochemical analysis, by sequencing of its 16S rRNA genes, and by DNA-DNA hybridization. Virulence determinants known to occur in the genus Bacteroides, such the bft enterotoxin and other enzymatic activities involved in the degradation of the extracellular matrix and the capsular polysaccharide PS A, were absent in this strain. The investigation of the antibiotic susceptibility indicated that strain DSM 23964 was sensitive to metronidazole, meropenem agents, and clindamycin. Resistance to penicillin and ampicillin was identified to be conferred by the β-lactamase cepA gene and could therefore be restored by adding β-lactamase inhibitors. The localization of the cepA gene in the genome of strain DSM 23964 and the absence of detectable plasmids further suggest that a transfer of β-lactamase activity or the acquisition of other antibiotic resistances are highly improbable. Taken together, the presented data indicate that the strain B. xylanisolvens DSM 23964 has no virulence potential. Since it also resists the action of gastric enzymes and low-pH conditions, this strain is an interesting candidate for further investigation of its safety and potential health-promoting properties.
authors.affiliation: Glycotope GmbH, Berlin, Germany. philippe.ulsemer@glycotope.com
authors.forename: Philippe
authors.initials: P
authors.lastname: Ulsemer
authors.forename: Kawe
authors.initials: K
authors.lastname: Toutounian
authors.forename: Jens
authors.initials: J
authors.lastname: Schmidt
authors.forename: Uwe
authors.initials: U
authors.lastname: Karsten
authors.forename: Steffen
authors.initials: S
authors.lastname: Goletz
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D001439:Bacteroides / Q000145:classification / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*; D016000:Cluster Analysis; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D005243:Feces / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009693:Nucleic Acid Hybridization; D010802:Phylogeny; D010957:Plasmids; D019936:Probiotics / Q000009:adverse effects*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D037521:Virulence Factors / Q000235:genetics; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012336:RNA, Ribosomal, 16S; D037521:Virulence Factors; D001618:beta-Lactamases
references.citation: Probiotics Antimicrob Proteins. 2009 Dec;1(2):113-20
references.pmid: 26783165
references.citation: Front Biosci (Landmark Ed). 2010 Jan 01;15:25-34
references.pmid: 20036803
references.citation: Clin Microbiol Infect. 2009 Aug;15(8):796-802
references.pmid: 19438622
references.citation: Int J Syst Evol Microbiol. 2008 Apr;58(Pt 4):1008-13
references.pmid: 18398210
references.citation: Int J Syst Evol Microbiol. 2006 May;56(Pt 5):931-935
references.pmid: 16627634
references.citation: Antimicrob Agents Chemother. 1976 Oct;10(4):736-52
references.pmid: 984809
references.citation: Int J Cancer. 1995 Jan 27;60(3):400-6
references.pmid: 7829251
references.citation: Cell Host Microbe. 2009 Jun 18;5(6):522-6
references.pmid: 19527880
references.citation: Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9
references.pmid: 20566854
references.citation: Science. 1993 Oct 15;262(5132):416-9
references.pmid: 8211161
references.citation: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references.pmid: 9254694
references.citation: Nucleic Acids Res. 1979 Nov 24;7(6):1513-23
references.pmid: 388356
references.citation: J Clin Microbiol. 1981 Aug;14(2):153-6
references.pmid: 6268657
references.citation: Curr Microbiol. 2007 May;54(5):348-53
references.pmid: 17486409
references.citation: Science. 1978 Aug 4;201(4354):455-7
references.pmid: 351810
references.citation: Infect Immun. 2006 Apr;74(4):2304-16
references.pmid: 16552061
references.citation: J Gastrointest Surg. 1999 Mar-Apr;3(2):200-7
references.pmid: 10457347
references.citation: Gut Microbes. 2010 May-Jun;1(3):164-85
references.pmid: 21327023
references.citation: Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1160-6
references.pmid: 18796545
references.citation: FEMS Microbiol Lett. 2003 May 16;222(1):9-16
references.pmid: 12757940
references.citation: Mol Biol Evol. 1987 Jul;4(4):406-25
references.pmid: 3447015
references.citation: Biosci Biotechnol Biochem. 2009 Feb;73(2):372-7
references.pmid: 19202287
references.citation: Food Chem Toxicol. 2009 Jun;47(6):1231-8
references.pmid: 19248815
references.citation: J Nutr Sci Vitaminol (Tokyo). 2006 Apr;52(2):105-12
references.pmid: 16802690
references.citation: Infect Immun. 2001 Jul;69(7):4342-50
references.pmid: 11401972
references.citation: Appl Environ Microbiol. 2008 May;74(9):2882-93
references.pmid: 18344347
references.citation: Appl Microbiol. 1974 Jun;27(6):1031-3
references.pmid: 4364608
references.citation: Gut. 2010 Apr;59(4):461-9
references.pmid: 19736360
references.citation: Curr Opin Infect Dis. 2010 Oct;23(5):470-4
references.pmid: 20697287
references.citation: Mem Inst Oswaldo Cruz. 2004 May;99(3):307-12
references.pmid: 15273805
references.citation: Microbiol Immunol. 1999;43(9):893-7
references.pmid: 10553682
references.citation: Microbiology (Reading). 2000 May;146 ( Pt 5):1241-1254
references.pmid: 10832652
references.citation: Appl Environ Microbiol. 2007 Sep;73(18):5742-9
references.pmid: 17616613
references.citation: Biotechnol Lett. 2005 Aug;27(16):1183-8
references.pmid: 16158261
references.citation: J Bacteriol. 1978 Apr;134(1):84-91
references.pmid: 148460
references.citation: Adv Immunol. 2010;106:61-91
references.pmid: 20728024
references.citation: Diagn Microbiol Infect Dis. 1992 Jul;15(5):459-63
references.pmid: 1643825
references.citation: Nutr Rev. 2011 May;69(5):245-58
references.pmid: 21521227
references.citation: Mol Biol Evol. 2007 Aug;24(8):1596-9
references.pmid: 17488738
references.citation: Lett Appl Microbiol. 2003;36(4):213-6
references.pmid: 12641713
references.citation: Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1081-93
references.pmid: 1295763
references.citation: Cell Growth Differ. 1994 Sep;5(9):967-73
references.pmid: 7819134
references.citation: Int J Syst Evol Microbiol. 2006 Jul;56(Pt 7):1639-1643
references.pmid: 16825642
references.citation: J Comput Biol. 2000 Feb-Apr;7(1-2):203-14
references.pmid: 10890397
references.citation: Int J Syst Evol Microbiol. 2007 Oct;57(Pt 10):2259-2261
references.pmid: 17911292
references.citation: J Antimicrob Chemother. 2008 Nov;62(5):942-7
references.pmid: 18775891
references.citation: Appl Microbiol. 1968 Sep;16(9):1434-6
references.pmid: 4877667
references.citation: Infect Immun. 2001 Oct;69(10):6044-54
references.pmid: 11553542
references.citation: Lett Appl Microbiol. 1996 May;22(5):361-5
references.pmid: 8672275
references.citation: Clin Microbiol Rev. 2007 Oct;20(4):593-621
references.pmid: 17934076
references.citation: J Clin Microbiol. 1976 Nov;4(5):458-60
references.pmid: 186484
references.citation: Antimicrob Agents Chemother. 1981 Dec;20(6):731-5
references.pmid: 7325639
references.citation: Nat Immunol. 2003 Mar;4(3):269-73
references.pmid: 12548285